Last updated on September 2018

Study to Compare Delafloxacin to Moxifloxacin for the Treatment of Adults With Community-acquired Bacterial Pneumonia


Brief description of study

The purpose of this study is to evaluate the safety and efficacy of delafloxacin compared to moxifloxacin in the treatment of adult patients with community-acquired pneumonia.

Detailed Study Description

The purpose of this study is to determine if delafloxacin, an investigational drug, is safe and effective in the treatment of community-acquired bacterial pneumonia compared with moxifloxacin, or linezolid in the case of confirmed MRSA.

Clinical Study Identifier: NCT02679573

Contact Investigators or Research Sites near you

Start Over

Megan Quintas

Melinta 306 Study Site
Ruse, Bulgaria